BioCentury | Jun 25, 2020
Deals
June 24 Quick Takes: CSL pays $450M for uniQure’s hemophilia gene therapy; plus Merck-Yumanity, Editas, Compass-Olivia, Century-Empirica, Tetraphase-La Jolla
...Wednesday. After merger, Compass raises $60M Antibody therapeutics company Compass completed a reverse merger with Olivia Ventures Inc....
